Morphisec Stock
Morphisec provides endpoint threat prevention by making sure attackers never find the targets they seek.
Sign up today and learn more about Morphisec Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Morphisec Stock
Morphisec’s patented suite of security defense tools protects enterprises against targeted and zero-day attacks utilizing the concept of polymorphism - in other words, by turning attackers’ tactics back on themselves. Morphisec neutralizes attacks at the moment they happen, no matter what form they take. Stop wasting resources chasing after hackers and getting derailed by false alarms. All via a lightweight 2 MB DLL with no run-time components and zero performance impact.
Funding History
| July 2015 | $7.0M |
|---|---|
| February 2018 | $12.0M |
Management
Chief Science Officer
Mordechai Guri
Co-Founder, CEO & Board Member
Ronen Yehoshua
Co-Founder
Dudu Mimran
Vice President, US Sales
Arthur Braunstein
Press
prweb - Mar, 1 2024
Cybersecurity startup Morphisec appoints Ron Reinfeld as CEOprweb - Jan, 24 2024
Morphisec Recognized as a Sample Vendor in Two Concurrent Gartner Emerging Tech Reportsblog - Jan, 19 2024
Windows Server 2012 End of Life –– How do You Secure Legacy Servers?blog - Dec, 22 2023
Automated Moving Target Defense included in the Gartner® Hype Cycle™ for Endpoint Security, 2023thenewstack - Dec, 22 2023
Chae$ 4: The Evolution of a CyberthreatEquityZen Recognized As:
